About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Depression Clinical Trials | 3,199 Studies Recruiting

Clinical TrialsDepression

Depression Clinical Trials

Browse 3,199 clinical trials for depression. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 3,199 trials

CompletedThe Serotonin Transporter Availability for Prognosing Major Depressive Disorder (MDD) Treatment and Detecting MDDObjectives: 1.NCT02473783 TerminatedInflammation and Electroconvulsive TherapyThe purpose of this study is to explore whether electroconvulsive therapy (ECT) accidentally leads to a side effect of brain inflammation.NCT02095639·Toronto, Ontario CompletedNon-invasive Brain Stimulation and Cognitive Processing in DepressionDepression is a serious mental health problem that affects millions.NCT01875419·London

Related Searches

major depressivetrials mddtrials

Data from ClinicalTrials.govTerms

CompletedExploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine SystemThis study will assess the helpfulness of the integrated call center in optimizing use of the Digital Medicine System in adult subjects with Schizophrenia, Major Depressive…NCT02722967·Granada Hills, California and 3 others

TerminatedUse of Ketamine to Enhance Electroconvulsive Therapy (ECT) in DepressionThe primary objectives of this study are to investigate the potential for ketamine anesthesia to increase the antidepressant efficacy of Electroconvulsive therapy (ECT) and to…NCT01309581·New York, New York

RecruitingPeer-Delivered Behavioral Activation in a CCBHCLow-income individuals have limited access to evidence-based interventions for mental health.NCT07219394·Detroit, Michigan

Not yet recruitingFunctional Magnetic Resonance Imaging Study of Inhibitory Control in Bipolar Disorder and Major Depressive DisorderBipolar disorder and unipolar depressive disorder are two chronic mood disorders associated with a significant social impact, even during euthymic phases.NCT07503275·Reims

CompletedEvaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving TreatmentThis study will evaluate the effectiveness of escitalopram to prevent depression in head and neck cancer patients receiving treatment.NCT00536172·Omaha, Nebraska

Not yet recruitingEarly Brainwave Biomarkers for Personalized Neuromodulation in Treatment-resistant DepressionThis study tests whether a brain stimulation treatment for depression called intermittent theta burst stimulation (iTBS) can be improved by tailoring it to each individual.NCT07528157·Stanford, California

CompletedFeasibility of Resistance Exercise to Treat Major Depression Via Cerebrovascular MechanismsThis project is a single-arm pilot trial to investigate the feasibility, acceptability, and plausible efficacy of a 16-week resistance exercise training (RET) program for…NCT05695365·Ames, Iowa

CompletedA Study to Test How Well Different Doses of BI 1569912 Are Tolerated and How Well They Work in People With Depression Who Take Anti-depressive MedicationThis study is open to adults between 18 and 65 years of age who have depression (major depressive disorder).NCT04937829·Garden Grove, California and 9 others

Enrolling by invitationEffect of Theta-burst rTMS Therapy on the Clinical and Cognitive Symptoms of Patients With Therapy Resistant Depression and Response Prediction With Neuroimaging Methods.The primary aim of the study is to find the combination of neuroimaging-related markers, demographics, and clinical characteristics that predict the response of patients with…NCT07207239·Budapest, Pest County

UnknownA Biological Signature for the Early Differential Diagnosis of PsychosisSchizophrenia (SZ) and mood disorders (BD, MDD) are among the most disabling disorders worldwide, with a relevant social, functional, and economic burden.NCT06515522

CompletedBrainsway DTMS for Treatment of MDD Using iTBSThe safety and effectiveness of the BrainsWay deep transcranial magnetic stimulation (DTMS) device for the intended use of Major Depressive Disorder (MDD) using the intermittent…NCT04679753·Yorkton, Saskatchewan

TerminatedStudy of Rapastinel as Monotherapy in Patients With Major Depressive Disorder (MDD)The study will evaluate the efficacy, safety, and tolerability of 225 milligrams (mg) and 450 milligrams (mg) of Rapastinel, compared to placebo in participants with major…NCT03675776·Gyöngyös and 22 others

CompletedFeasibility of Internet-delivered CBT for Adolescents With DepressionPrior to a properly powered randomized controlled study, evaluating efficacy and cost-effectiveness of ICBT, we will conduct a pilot study to investigate if the trial design is…NCT04117789·Stockholm

CompletedA Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDDThis is a Double-blind Study Evaluating Desvenlafaxine Succinate (DVS SR) Sustained Release vs Placebo in the Treatment of Children and Adolescent Outpatients with Major…NCT01372150·Dothan, Alabama and 42 others

CompletedSMILE Trial - Imaging Sub-StudyThis is a pilot sub-study of an ongoing trial comparing N2O to midazolam in MDD and will examine neuroimaging correlates of treatment response.NCT05528718·Toronto, Ontario

CompletedTrial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive DisorderThis is a phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel-arm trial to assess the efficacy, safety, and tolerability of centanafadine once-daily (QD)…NCT05536414·Yuma, Arizona and 61 others

CompletedSafety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive DisorderThe purpose is to evaluate the safety and usefulness of the investigational drug, vilazodone in depression.NCT00290914

PreviousPage 2 of 160Next